Clinical Trial Update: Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome

View source ↗

Summary

A completed clinical trial investigating methylprednisolone for patients with severe acute respiratory syndrome due to coronavirus infections, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infections
• Respiratory Distress Syndrome
• Respiratory Syndrome

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: University of Trieste | Conditions: Severe Acute Respiratory Syndrome (SARS) Pneumonia, Coronavirus Infections | Status: COMPLETED | Results posted: 2020-06-04